922 results on '"Yokose, Tomoyuki"'
Search Results
2. Primary lung chordoma: a case report
3. Primary omental smooth muscle tumor in an adult male: a diagnostic dilemma for leiomyoma: a case report
4. Non-invasive intraductal oncocytic papillary neoplasm forming a protruding lesion toward the duodenum from the accessory papilla: a case report
5. Genetic analysis of low-grade adenosquamous carcinoma of the breast progressing to high-grade metaplastic carcinoma
6. Proteome analysis of CD5-positive diffuse large B cell lymphoma FFPE tissue reveals downregulation of DDX3X, DNAJB1, and B cell receptor signaling pathway proteins including BTK and Immunoglobulins
7. Histological markers, sickle-shaped blood vessels, myxoid area, and infiltrating growth pattern help stratify the prognosis of patients with myxofibrosarcoma/undifferentiated sarcoma
8. Differential diagnosis of uterine adenosarcoma: identification of JAZF1-BCORL1 rearrangement by comprehensive cancer genomic profiling
9. Effect of Surgical Treatment for N2-Positive c-stage III Non-Small Cell Lung Carcinoma in the “PACIFIC” Era
10. Lipophagy-ICAM-1 pathway associated with fatty acid and oxygen deficiencies is involved in poor prognoses of ovarian clear cell carcinoma
11. Evaluating Cellularity Estimation Methods: Comparing AI Counting with Pathologists’ Visual Estimates
12. Diagnostic significance of reassessment of prostate biopsy specimens by experienced urological pathologists at a high-volume institution
13. Prognostic factors for relapse-free survival in stage IB-IIIA primary lung adenocarcinoma by epidermal growth factor receptor mutation status
14. Retroperitoneal Doege–Potter syndrome with intraoperative blood glucose monitoring.
15. Successful treatment with brentuximab vedotine for a patient with very late relapse of limited stage classic Hodgkin lymphoma
16. Effect of epidermal growth factor receptor gene mutation on the prognosis of pathological stage II–IIIA (8th edition TNM classification) primary lung cancer after curative surgery
17. Right middle lobe and S6 sleeve lobectomy for pulmonary mucoepidermoid carcinoma originating from the bronchus intermedius: A case report
18. Evaluation of pancreatic cancer specimens for comprehensive genomic profiling
19. Characterization of KIF20B as a novel prognostic biomarker and therapeutic target for breast cancer
20. Machine learning-based image analysis for accelerating the diagnosis of complicated preneoplastic and neoplastic ductal lesions in breast biopsy tissues
21. Comparison of SP263 and 22C3 pharmDx assays to test programmed death ligand‐1 (PD‐L1) expression in surgically resected non‐small cell lung cancer.
22. Mutation profile and programmed death ligand 1 status of patients with non‐small cell lung cancer diagnosed with “adenocarcinoma” and “non‐small cell carcinoma favor adenocarcinoma”
23. Ten-year follow-up outcomes of limited resection trial for radiologically less-invasive lung cancer
24. Sufficient Multidisciplinary Discussion Can Make Patients’ Outcomes Better in the Treatment for Stage III Non–Small-Cell Lung Carcinoma - Reply to Ohri et al.
25. Detection of EGFR mutation of pulmonary adenocarcinoma in sputum using droplet digital PCR
26. Galectin-9 expression as a poor prognostic factor in patients with renal cell carcinoma
27. CD271 is a negative prognostic factor and essential for cell proliferation in lung squamous cell carcinoma
28. Comparison between next‐generation sequencing and multiplex polymerase chain reaction assays for nonsmall‐cell lung cancer molecular diagnosis.
29. Impact of RBM10 and PD-L1 expression on the prognosis of pathologic N1–N2 epidermal growth factor receptor mutant lung adenocarcinoma
30. Glutamine deficiency drives transforming growth factor‐β signaling activation that gives rise to myofibroblastic carcinoma‐associated fibroblasts
31. Increased RUNX3 expression mediates tumor‐promoting ability of human breast cancer‐associated fibroblasts
32. KMT2C expression and DNA homologous recombination repair factors in lung cancers with a high-grade fetal adenocarcinoma component
33. Pulmonary adenocarcinoma with high-grade fetal adenocarcinoma component has a poor prognosis, comparable to that of micropapillary adenocarcinoma
34. Clinicopathological and genomic analysis of double-hit follicular lymphoma: comparison with high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements
35. Efficacy of Platinum-Based Adjuvant Chemotherapy on Prognosis of Pathological Stage II/III Lung Adenocarcinoma based on EGFR Mutation Status: A Propensity Score Matching Analysis
36. Clinical Significance of Pre-treatment Circumferential Tumor Location in Patients With cStage IB-III Esophageal Squamous Cell Cancer
37. Cribriform pattern and intraductal carcinoma of the prostate can have a clinicopathological impact, regardless of their percentage and/or number of cores
38. Clinicopathological, immunohistochemical, and mutational analyses of pulmonary enteric adenocarcinoma: usefulness of SATB2 and β-catenin immunostaining for differentiation from metastatic colorectal carcinoma
39. Long‐term changes in psoas muscle mass after lobectomy and segmentectomy for early‐stage lung cancer.
40. Expression of vascular endothelial growth factor receptor 2 and clinical response to lenvatinib in patients with anaplastic thyroid cancer
41. A case of retroperitoneal Doege-Potter syndrome with continuous intraoperative blood glucose monitoring
42. Case report: anaplastic lymphoma kinase (ALK) rearranged adenocarcinoma with high level of microsatellite instability response to pembrolizumab
43. Abstract 2200: Transcriptomic profiling identifies an amino acid metabolism-related prognostic gene signature in lung adenocarcinoma patients
44. Liposarcoma of the pleural cavity
45. Fig. S2 from Chemotherapy-Induced IL34 Enhances Immunosuppression by Tumor-Associated Macrophages and Mediates Survival of Chemoresistant Lung Cancer Cells
46. Data from Chemotherapy-Induced IL34 Enhances Immunosuppression by Tumor-Associated Macrophages and Mediates Survival of Chemoresistant Lung Cancer Cells
47. Supplementary Tables 1 and 2 from Chemotherapy-Induced IL34 Enhances Immunosuppression by Tumor-Associated Macrophages and Mediates Survival of Chemoresistant Lung Cancer Cells
48. PD-L1 expression in anaplastic thyroid carcinoma treated with lenvatinib
49. Bone marrow adipocytes induce cancer‐associated fibroblasts and immune evasion, enhancing invasion and drug resistance
50. Cancer cell‐derived CD69 induced under lipid and oxygen starvation promotes ovarian cancer progression via fibronectin
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.